Richard E. Buller

6.3k total citations
118 papers, 4.7k citations indexed

About

Richard E. Buller is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Richard E. Buller has authored 118 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Reproductive Medicine, 40 papers in Oncology and 31 papers in Molecular Biology. Recurrent topics in Richard E. Buller's work include Ovarian cancer diagnosis and treatment (43 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Cancer-related Molecular Pathways (15 papers). Richard E. Buller is often cited by papers focused on Ovarian cancer diagnosis and treatment (43 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Cancer-related Molecular Pathways (15 papers). Richard E. Buller collaborates with scholars based in United States, Germany and Netherlands. Richard E. Buller's co-authors include Anil K. Sood, Joel I. Sorosky, Barrie Anderson, Bert W. O’Malley, William T. Schrader, Mark S. Shahin, Jeffrey S. Skilling, Joseph P. Connor, Thomas Buekers and Susan K. Lutgendorf and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Reviews Drug Discovery.

In The Last Decade

Richard E. Buller

116 papers receiving 4.4k citations

Peers

Richard E. Buller

ONCOL

GENET

George D. Wilbanks United States

Lukas Hefler Austria

Judith K. Wolf United States

Kimberly K. Leslie United States

Pax H.B. Willemse Netherlands

Olaf Ortmann Germany

Kian Behbakht United States

G. Larry Maxwell United States

Curt W. Burger Netherlands

Henrik Alfthan Finland

George D. Wilbanks United States

Richard E. Buller

1.6k ×0.9

1.3k ×0.9

ONCOL

1.1k ×0.8

1.3k ×1.2

842 ×0.9

GENET

Citations per year, relative to Richard E. Buller Richard E. Buller (= 1×) peers George D. Wilbanks

Countries citing papers authored by Richard E. Buller

Since Specialization

Citations

This map shows the geographic impact of Richard E. Buller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Buller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Buller more than expected).

Fields of papers citing papers by Richard E. Buller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Buller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Buller. The network helps show where Richard E. Buller may publish in the future.

Co-authorship network of co-authors of Richard E. Buller

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Buller. A scholar is included among the top collaborators of Richard E. Buller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Buller. Richard E. Buller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Seungchang, et al.. (2006). CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer. International Journal of Gynecological Cancer. 16(S1). 190–194. 6 indexed citations

McMeekin, D. Scott, Alan N. Gordon, Jeffrey M. Fowler, et al.. (2003). A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer. Gynecologic Oncology. 90(1). 64–69. 55 indexed citations

Wen, Shu Fen, Erlinda Quijano, Michael J. Grace, et al.. (2003). Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer. Cancer Gene Therapy. 10(3). 224–238. 35 indexed citations

Buller, Richard E., Ingo B. Runnebaum, Beth Y. Karlan, et al.. (2002). A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Cancer Gene Therapy. 9(7). 553–566. 138 indexed citations

Geisler, John P., et al.. (2001). Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP). Human Mutation. 18(4). 337–344. 18 indexed citations

Buekers, Thomas, Joel I. Sorosky, Barrie Anderson, & Richard E. Buller. (2000). Transabdominal Biopsy is a Poor Prognostic Factor in Stage-IV Ovarian Carcinoma. Journal of Gynecologic Surgery. 16(3). 113–117. 1 indexed citations

Shahin, Mark S., et al.. (2000). The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma. Cancer. 89(9). 2006–2017. 106 indexed citations

Minassian, Vatché A., Anil K. Sood, Patrick Lowe, et al.. (2000). Longterm central venous access in gynecologic cancer patients11No competing interests declared.. Journal of the American College of Surgeons. 191(4). 403–409. 44 indexed citations

Sood, Anil K., et al.. (1999). Cyclosporin A Reverses Chemoresistance in Patients With Gynecologic Malignancies. Neoplasia. 1(2). 118–122. 12 indexed citations

10.

Asbury, Robert F., John A. Blessing, Richard E. Buller, et al.. (1998). Amonafide in Patients With Leiomyosarcoma of the Uterus. American Journal of Clinical Oncology. 21(2). 145–146. 15 indexed citations

11.

Lallas, Thomas A. & Richard E. Buller. (1998). Optimization of PCR and Electrophoresis Conditions Enhances Mutation Analysis of the BRCA1 Gene. Molecular Genetics and Metabolism. 64(3). 173–176. 10 indexed citations

12.

Sood, Anil K., et al.. (1998). Taxol Hypersensitivity: Rapid Retreatment Is Safe and Cost Effective. Gynecologic Oncology. 68(1). 25–28. 35 indexed citations

13.

Sorosky, Joel I., et al.. (1996). Prosthetic Grafts of the Abdominal Wall in Obstetric and Gynecology Patients. Journal of Gynecologic Surgery. 12(4). 257–260. 1 indexed citations

14.

Buller, Richard E., et al.. (1996). CA 125 kinetics: A cost-effective clinical tool to evaluate clinical trial outcomes in the 1990s. American Journal of Obstetrics and Gynecology. 174(4). 1241–1254. 41 indexed citations

15.

Squatrito, Robert C., Joseph P. Connor, & Richard E. Buller. (1995). Comparison of a Novel Redox Dye Cell Growth Assay to the ATP Bioluminescence Assay. Gynecologic Oncology. 58(1). 101–105. 36 indexed citations

16.

Morris, Peter C., James R. Anderson, Barrie Anderson, & Richard E. Buller. (1995). Steroid Hormone Receptor Content and Lymph Node Status in Endometrial Cancer. Gynecologic Oncology. 56(3). 406–411. 23 indexed citations

17.

Morris, Peter C., et al.. (1995). Blood Transfusion and the Risk of Recurrence in Stage IB Cervical Cancer. Gynecologic Oncology. 57(3). 401–406. 15 indexed citations

18.

Mannel, Robert S., Alberto Manetta, Richard E. Buller, et al.. (1995). Use of Ileocecal Continent Urinary Reservoir in Patients with Previous Pelvic Irradiation. Gynecologic Oncology. 59(3). 376–378. 19 indexed citations

19.

Bénda, J, et al.. (1994). An Unusual Extrauterine Variant of Adenosarcoma with Multiple Recurrences over 16 Years. Gynecologic Oncology. 53(1). 131–137. 6 indexed citations

20.

Connor, Joseph P., et al.. (1994). In Vitro Growth Effects of Colony-Stimulating Factors in Ovarian Cancer. Gynecologic Oncology. 52(3). 347–352. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact